Exosomes loaded with STAT3 inhibitors that enter the brain by crossing the BBB, after nasal administration, are selectively taken up by microglia and inhibit the expression of inflammatory cytokines, such as IL-1β and IL-6, ultimately retarding glioma cell growth [214]. The gene discussed is STAT3; the disease is glioma.